Anaptysbio Inc (ANAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 250,456 | 171,017 | 113,596 | 81,189 | 51,232 |
| Marketable Securities | 143,197 | 203,210 | 313,486 | 167,218 | 0 |
| Receivables | N/A | N/A | 174 | 1,601 | 5,343 |
| TOTAL | $396,561 | $377,733 | $434,216 | $252,696 | $58,208 |
| Non-Current Assets | |||||
| PPE Net | 1,783 | 1,618 | 1,445 | 665 | 471 |
| Investments And Advances | 17,546 | 54,305 | 73,128 | 75,897 | 0 |
| Other Non-Current Assets | 662 | 1,541 | 208 | 106 | 3,501 |
| TOTAL | $19,991 | $57,464 | $74,781 | $76,668 | $3,972 |
| Total Assets | $416,552 | $435,197 | $508,997 | $329,364 | $62,180 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,217 | 16,237 | 5,443 | 2,323 | 2,278 |
| Accrued Expenses | 15,262 | 11,052 | 8,761 | 4,875 | 3,429 |
| Other current liabilities | 342 | 871 | 58 | 17 | 1 |
| TOTAL | $19,821 | $29,535 | $21,836 | $14,090 | $5,708 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | 7,553 | 13,809 |
| Other Non-Current Liabilities | 0 | 654 | 796 | 0 | 3,241 |
| TOTAL | $N/A | $654 | $796 | $7,693 | $17,204 |
| Total Liabilities | $19,821 | $30,189 | $22,632 | $21,783 | $22,912 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 27,366 | 27,265 | 26,987 | 23,810 | N/A |
| Common Shares | 27 | 27 | 27 | 24 | 3 |
| Retained earnings | -263,957 | -244,026 | -146,690 | -85,034 | -54,923 |
| Other shareholders' equity | -4 | 338 | -223 | -426 | 77,516 |
| TOTAL | $396,731 | $405,008 | $486,365 | $307,581 | $39,268 |
| Total Liabilities And Equity | $416,552 | $435,197 | $508,997 | $329,364 | $62,180 |